ProfileGDS4718 / 224318_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 96% 93% 93% 95% 94% 94% 94% 92% 92% 94% 94% 93% 93% 94% 93% 94% 94% 95% 93% 93% 94% 94% 93% 93% 94% 96% 96% 96% 93% 96% 94% 93% 94% 95% 94% 95% 93% 96% 93% 95% 95% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.261995
GSM549102patient 115, normal, homogenized [OPG study]10.01194
GSM549104patient 119, normal, homogenized [OPG study]10.600696
GSM549108patient 138, normal, homogenized [OPG study]9.6422393
GSM549119patient 077, normal, homogenized [OPG study]9.7866193
GSM549133patient 032, cancer, homogenized [OPG study]10.198295
GSM549139patient 042, cancer, homogenized [OPG study]10.037494
GSM549099patient 107, normal, homogenized [OPG study]9.975794
GSM549109patient 139, normal, homogenized [OPG study]9.9830294
GSM549110patient 046, normal, homogenized [OPG study]9.6797792
GSM549114patient 063, normal, homogenized [OPG study]9.7642892
GSM549122patient 082, normal, homogenized [OPG study]10.079494
GSM549134patient 033, cancer, homogenized [OPG study]9.865194
GSM549136patient 036, cancer, homogenized [OPG study]9.8867293
GSM549140patient 044, cancer, homogenized [OPG study]9.7303293
GSM549111patient 047, normal, homogenized [OPG study]10.072394
GSM549113patient 057, normal, homogenized [OPG study]9.9950293
GSM549132patient 031, cancer, homogenized [OPG study]9.8383694
GSM549137patient 038, cancer, homogenized [OPG study]9.7829294
GSM549142patient 047, cancer, homogenized [OPG study]9.636995
GSM549100patient 110, normal, homogenized [OPG study]9.7917193
GSM549107patient 135, normal, homogenized [OPG study]9.8859193
GSM549115patient 068, normal, homogenized [OPG study]10.118794
GSM549116patient 072, normal, homogenized [OPG study]10.030694
GSM549120patient 078, normal, homogenized [OPG study]9.8999393
GSM549131patient 030, cancer, homogenized [OPG study]9.758893
GSM549118patient 074, normal, homogenized [OPG study]10.181694
GSM549129patient 027, cancer, homogenized [OPG study]10.362996
GSM549123patient 088, normal, homogenized [OPG study]10.576196
GSM549124patient 006, cancer, homogenized [OPG study]10.313696
GSM549126patient 015, cancer, homogenized [OPG study]9.6883493
GSM549128patient 025, cancer, homogenized [OPG study]10.491496
GSM549103patient 117, normal, homogenized [OPG study]9.8772494
GSM549117patient 073, normal, homogenized [OPG study]9.9021593
GSM549138patient 041, cancer, homogenized [OPG study]9.8841994
GSM549141patient 045, cancer, homogenized [OPG study]10.367195
GSM549130patient 028, cancer, homogenized [OPG study]9.9172294
GSM549101patient 111, normal, homogenized [OPG study]10.123295
GSM549105patient 128, normal, homogenized [OPG study]9.7830793
GSM549106patient 134, normal, homogenized [OPG study]10.650596
GSM549112patient 048, normal, homogenized [OPG study]9.8499393
GSM549125patient 011, cancer, homogenized [OPG study]10.111595
GSM549127patient 024, cancer, homogenized [OPG study]10.01595
GSM549135patient 035, cancer, homogenized [OPG study]10.33695